节假日导致的放疗中断对鼻咽癌患者生存产生不良影响:基于大规模回顾性数据与临床试验的联合分析
该研究纳入5035例接受放疗联合诱导化疗和(或)同步化疗的局部晚期鼻咽癌非试验患者,按春节导致的放疗中断分组,比较总生存(OS)与无失败生存(FFS),并用3项III期试验(N=1465)个体数据验证。结果显示春节导致的放疗中断与显著更低的OS(P=0.009)和FFS(P=0.033)相关,而诱导化疗中断无此关联。作者推荐这些患者接受足量顺铂同步放疗。
要点
- 春节导致的放疗中断与鼻咽癌患者显著更低的OS(P=0.009)和FFS(P=0.033)相关。
- 诱导化疗中断与生存无显著关联。
- 作者推荐鼻咽癌患者接受足量顺铂同步放疗。
核心结论
- 鼻咽癌患者较差的生存与春节导致的放疗中断相关。
- 作者推荐这些患者接受足量顺铂同步放疗。
研究设计与样本
- 纳入5035例接受放疗联合诱导化疗和(或)同步化疗的局部晚期鼻咽癌非试验患者,按春节导致的放疗中断分为两组。
- 采用倾向性评分匹配数据集分析放疗中断时机(春节期间或春节之外)对生存的影响。
- 采用排序对应分析确定放疗延长的预后预测截断值,并据此按延迟天数和化疗细节进行亚组分析。
- 使用3项III期鼻咽癌试验(NCT00677118、NCT01245959、NCT01872962)的个体患者数据(N=1465)进行验证。
主要发现
- 放疗中断最常观察到于12月至次年1月之间。
- 春节导致的放疗中断与显著更低的OS(P=0.009)和FFS(P=0.033)相关。
- 诱导化疗中断与生存无显著关联。
- 在两个匹配比较组中,春节期间放疗中断比春节之外更可能导致FFS下降(P=0.046),但该结果在临床试验数据验证中或基于5天延迟时间的亚组分析中未观察到。
- 未接受同步化疗与春节导致的放疗中断对FFS的负面影响相关(P=0.002),顺铂累积剂量<200 mg与对OS的负面影响相关(P=0.010)。
关键数值与推荐
- 春节导致的放疗中断与更低的OS(P=0.009)和FFS(P=0.033)相关。
- 春节期间放疗中断比春节之外更可能导致FFS下降(P=0.046)。
- 未接受同步化疗与FFS负面影响相关(P=0.002)。
- 顺铂累积剂量<200 mg与OS负面影响相关(P=0.010)。
临床怎么用
- 作者推荐鼻咽癌患者接受足量顺铂同步放疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of radiotherapy interruption due to the Spring Festival holidays in China on the survival of patients with nasopharyngeal carcinoma (NPC) is unclear. METHODS: Nontrial patients with locoregionally advanced NPC receiving radiotherapy plus induction chemotherapy (IC) and/or concurrent chemotherapy (CC) were included (N = 5035) and divided into two groups based on the Spring Festival-induced radiotherapy interruption. Kaplan-Meier curves for overall survival (OS) and failure-free survival (FFS) were compared between rival groups. Impact of the timing of radiotherapy interruption (during or outside the Spring Festival) on survival was investigated in a propensity score-matched dataset. We adopted ordination correspondence analysis to determine the cut-off of radiotherapy prolongation for prognostic prediction, and accordingly performed subgroup analysis based on delayed days and chemotherapy details. Individual patient data of three phase III NPC trials (NCT00677118, NCT01245959, NCT01872962) were used for validation (N = 1465). RESULTS: Radiotherapy interruption was most frequently observed between December to January of the following year. Significantly lower OS and FFS were associated with the Spring Festival-induced interruption of radiotherapy (P = 0.009 and 0.033, respectively), but not that interruption of IC. In two matched comparison groups, the timing of radiotherapy interruption during the Spring Festival was more likely to lead to a decrease in FFS than outside the Spring Festival (P = 0.046), which was not observed in the validation using clinical trial data or in the subgroup analysis based on the 5-day delayed time. The absence of CC and the accumulated dose of cisplatin < 200 mg were related to the negative influences of the Spring Festival-induced radiotherapy interruption on FFS (P = 0.002) and OS (P = 0.010), respectively. CONCLUSIONS: The poor survival of patients with NPC is associated with the Spring Festival-induced interruption of radiotherapy. We recommend that these patients receive adequate doses of cisplatin concurrently with radiotherapy.
引用
- Xu C, Yang KB, Feng RJ, et al. Radiotherapy interruption due to holidays adversely affects the survival of patients with nasopharyngeal carcinoma: a joint analysis based on large-scale retrospective data and clinical trials. Radiat Oncol. 2022. PMID: 35183221. doi:10.1186/s13014-022-02006-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。